HSCI Business Development
HSCI's stem cell research platform holds the potential to create a broad range of products and services, including cell replacement therapies, small molecule drugs, disease specific cell lines, implantable devices, and screening/research/modeling tools across a variety of disease areas, primarily: Diabetes, Nervous System Diseases, Blood Disorders, Cancer and Cardiovascular Disease. HSCI’s goal to “fulfill the promise of stem cell biology as the basis for cures and treatments” in selected disease areas is well served through active collaborations with the partners in our network. HSCI's business development program encompasses Harvard University and all of its affiliated hospitals and research institutions, and is centrally coordinated by Harvard’s Office of Technology Development. This model offers potential industrial partners a full suite of business development services and an efficient, single-point-of-access to learn about all stem cell opportunities throughout HSCI. A joint intellectual property (IP) oversight committee provides added value and leverages the capabilities and relationships within each constituent institution in order to provide vigorous patent protection and help ensure that new discoveries and therapies are made available for commercial development. HSCI’s strategy of bundling its robust portfolio of stem cell IP, coupled with its matrix approach to business development facilitates achievement of the Institute’s core mission: expediting and expanding the number of new therapies that will impact the practice of clinical medicine in order to alleviate human disease and suffering.
Contact:
Vivian Berlin, PhD
Director of Business Development
vivian_berlin@harvard.edu
(617) 496-0474
Elena Kfoury, SM
Associate Director of Business Development
elena_kfoury@harvard.edu
(617) 495-4373
Affiliate Institution Technology Transfer Websites:
Beth Israel Deaconess Medical Center
Brigham and Women’s Hospital
Children's Hospital Boston
Dana Farber Cancer Center
Harvard University
Immune Disease Institute
Joslin Diabetes Center
Massachusetts General Hospital
McLean Hospital